Pharmaceuticals and Medical Devices Safety Information
PMDA Updates
PMDA Risk Communications
Revision of PRECAUTIONS
5th PMDA Training Seminar
  • Pharmaceuticals and Medical Devices Safety Information
  • PMDA Updates
  • PMDA Risk Communications
  • Revisions of PRECAUTIONS
  • 5th PMDA Training Seminar
1st PMDA Medical Devices Training Seminar SEMINAR HIGHLIGHT DAY 1 DAY 2 DAY 3 DAY 4 DAY 5
What's NewRSS FeedsBack number
->July 29, 2014 new
Executive Summary of Pharmaceuticals and Medical Devices Safety Information posted: No 314, FY2014
->July 25, 2014 new
PMDA Updates (July, 2014) posted
->July 23, 2014
Past Presentation: Files added
Publications: Updated
->July 18, 2014
PMDA Medical Safety Information No.42
->July 18, 2014
PMDA Risk Communication: information on Carboplatin, Infliximab, Metronidazole, Doxycycline, Linezolid, Sugammadex, Pramipexole, Tolvaptan, and Carvedilol posted
->July 15, 2014 Updated
Revisions of PRECAUTIONS: Teriparatide, Inchinkoto, Loratadine, Ibuprofen/Pseudoephedrine/Chlorpheniramine/Dihydrocodeine/Caffeine, Ibuprofen/Pseudoephedrine/L-Carbocisteine/d-Chlorpheniramine/Dihydrocodeine/Caffeine, Simeprevir, Amphotericin B, Paroxetine
->July 14, 2014 Updated
PDF形式Updated program; The Second Indonesia - Japan Symposium (PDF)
->July 10, 2014
Nortification and Q&As of "Basic Principles on Electronic Submission of Study Data for New Drug Applications" posted
->July 9, 2014
Revisions of PRECAUTIONS (Summary of evaluation result): Teriparatide, Inchinkoto, Loratadine, Ibuprofen/Pseudoephedrine/Chlorpheniramine/Dihydrocodeine/Caffeine, Ibuprofen/Pseudoephedrine/L-Carbocisteine/d-Chlorpheniramine/Dihydrocodeine/Caffeine, Simeprevir, Amphotericin B, Paroxetine
->July 8, 2014 Updated
5th PMDA Training Seminar updated (Program Agenda)
->July 8, 2014
[JP] Pharmacopoeial Discussion Group (PDG) meeting was held in Rockville, U.S.A. on June 25 and 26, 2014 (Press Release)
->July 8, 2014 Updated
[JP] Pharmacopoeial Discussion Group (PDG) State of Work updated
->July 8, 2014 Updated
[JP] Timetable for implementation of harmonized documents by Pharamacopoeial Discussion Group (PDG) updated
->July 2, 2014
PMDA Medical Safety Information No.41
->June 30, 2014
MHLW Pharmaceuticals and Medical Devices Safety Information posted: No 313, FY2014
->June 27, 2014
PMDA Updates (June, 2014) posted
->June 20, 2014
PDF形式PMDA published an advertorial in Nature on May 1st 2014. (PDF)
->June 16, 2014
English translation of review report: Topiloric/Uriadec

>> Back number

International Programs

Implementation of PMDA International Strategic Plan through international regulatory harmonization, bilateral relationship, effective communication with relevant external parties, etc.

News and Reports
The Science Board

Framework to explore appropriate methods to evaluate medical products using advanced science and technology while exchanging opinions among academia and reviewers.

The Science Board The Science Board Subcommittees Outcome documents of the Science Board
Events / Symposia
Seminar
Past Presentations
Publications
Frequently Asked Questions (FAQ)
About PMDA
Drug and Medical Device Reviews

Scientific reviews and conformity audits of marketing authorization applications of drugs and medical devices, clinical trial consultations

Post-marketing Safety

Collection, analysis and dissemination of information related to the quality, efficacy and safety of pharmaceuticals and medical devices

Relief Services for Adverse Health Effects

Providing financial assistance for individuals affected by adverse drug reactions or infections from biological products